Brain disease is one of the biggest challenges for public health, society and the economy in Ireland. With one in three individuals affected over their lifetime, the annual burden on healthcare and welfare systems amounts to an estimated ¤30 billion. In Ireland alone, more than 800,000 people grapple with conditions impacting the brain and central nervous system, ranging from epilepsy and Amyotrophic lateral sclerosis (ALS) to Parkinson’s disease, Multiple Sclerosis (MS), and acquired brain injury. More than 30% of people affected will also contend with psychiatric disorders, adding complexity to their care.
FutureNeuro, an Ireland-based interdisciplinary research centre, is committed to alleviating this burden by accelerating progress and translating innovations into real-world solutions. With a focus on improving diagnosis, developing targeted treatments, and advancing healthcare management, the Centre is committed to making tangible differences to patient outcomes. Already, FutureNeuro’s research has led to transformative interventions, including genetic testing to identify patients most suitable for life-changing therapies.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
